ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Depression linked to chronic pain: Variability shown across patient characteristics April 23, 2024 $4.39 million NIH grant awarded to study the link between atrial myopathy and dementia October 10, 2023 UN report shows stagnant hunger rates and rising food insecurity July 25, 2024
$4.39 million NIH grant awarded to study the link between atrial myopathy and dementia October 10, 2023